Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2604Squamous Cell Carcinoma of Head and Neck 1880Thyroid Neoplasms 705Nasopharyngeal Carcinoma 627Carcinoma, Non-Small-Cell Lung 478Mouth Neoplasms 424Breast Neoplasms 383Neoplasms 381Oropharyngeal Neoplasms 359Melanoma 339Lung Neoplasms 319Colorectal Neoplasms 307Carcinoma, Squamous Cell 283Neoplasm Metastasis 255Ovarian Neoplasms 254Laryngeal Neoplasms 253Salivary Gland Neoplasms 236Uterine Cervical Neoplasms 234Stomach Neoplasms 223Esophageal Neoplasms 222Nasopharyngeal Neoplasms 221Pancreatic Neoplasms 213Prostatic Neoplasms 203Carcinoma, Renal Cell 201Thyroid Nodule 179Thyroid Cancer, Papillary 178Urinary Bladder Neoplasms 163Sarcoma 160Recurrence 143Hypopharyngeal Neoplasms 143

Interventions

Thyrotropin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recombinant Human Thyroid Stimulating Hormone × Head & Neck × Clear all
NCT06431620 2024-05-28

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
15 enrolled
Head & Neck

Recombinant Human Thyroid Stimulating Hormone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡